FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to C5 binding polypeptides, comprising a C5 binding motif, BM, which can be used in medicine. C5 binding polypeptide containing a C5 binding motif BM is obtained, wherein the motif consists of an amino acid sequence corresponding to EX2X3X4AX6X7EIDX11LPNLX16X17X18QWX21AFIX25X26LX28D, and the resulting polypeptide is used to treat a C5 related condition, for example, to inhibit the hemolytic effect.
EFFECT: invention provides improved preparation, purification and stability of a C5 binding polypeptide, which positively affects the treatment of a C5 related condition.
29 cl, 16 dwg, 8 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL POLYPEPTIDES | 2014 |
|
RU2681428C2 |
C5-BINDING POLYPEPTIDES | 2014 |
|
RU2714156C2 |
STRUCTURES OF FUSION PROTEIN IN SPIDER SILK FOR BINDING TO ORGANIC TARGET | 2011 |
|
RU2624036C2 |
LONG-ACTING INSULIN ANALOGUES AND THEIR DERIVATIVES | 2019 |
|
RU2781308C2 |
POLYPEPTIDES THAT BIND TO THE C5 COMPONENT OR TO SERUM ALBUMIN AND THEIR FUSION PROTEINS | 2018 |
|
RU2794359C2 |
METHOD FOR PRODUCTION OF ACTIVE FORM OF LONG-ACTING INSULIN ANALOGUE DERIVATIVE, USING CLOSTRIPAIN | 2019 |
|
RU2781307C2 |
POLYPEPTIDES | 2011 |
|
RU2577964C2 |
NOVEL POLYPEPTIDES | 2015 |
|
RU2725442C2 |
C5 ANTIBODIES AND METHODS FOR USING THEM | 2016 |
|
RU2742606C2 |
C5 ANTIBODY AND METHOD FOR PREVENTING AND TREATING COMPLEMENT-RELATED DISEASES | 2014 |
|
RU2663349C2 |
Authors
Dates
2018-05-21—Published
2013-02-19—Filed